Navigation Links
HT 96/200 Advanced Electroporation System from BTX

ProductsHT 96/200 Advanced Electroporation System from BTX
Company BTX
Item HT 96/200 Advanced Electroporation System
Price 
Description BTX, the leader in electroporation products and specialty electrodes, has developed a new and innovative product line for experiment optimization and large volume electroporation. The Advanced Electroporation System is a breakthrough in Molecular Delivery. The days of researchers struggling with tedious, multi-step procedures that typically limited the number of samples and cell types they could test are all about to change.

MOS Advanced Electroporation Systems
The Methods Optimization Systems, MOS 25 & MOS 96, allow you to boost your productivity by optimizing your conditions and increasing your yields and viability. Electroporate the MOS 25 or the Advanced MOS 96 plates in only seconds! These systems allow the user to quickly and efficiently optimize the electrical and biological parameters associated with any electroporation experiment. Now entire libraries can be screened rapidly and efficiently.

The key to the system are the patented multi-well plates. The MOS 25 is a 5 x 5, 25 well plate and the MOS 96 is a standard 8 x 12, 96 well plate. These plates allow the user to prepare an entire set of experiments and run them. This approach minimizes required sample and waste materials.

Both the MOS 25 and MOS 96 Advanced Electroporation Systems come complete with disposable multi-well Optimizer Plates, a Plate Handler and an ECM 830 Generator.

Info BTXBTX
BTX Instrument Division
Harvard Apparatus, Inc.
84 October Hill Road
Holliston, MA 01746-1388


Call BTX to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-439-8093
Customer Service: (800) 272-2775
Fax Number: (508) 429-5732
Web Site: http://www.btxonline.com/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Rabbit Anti-Conjugated Quinaldic Acid Polyclonal Antibody, Unconjugated from Advanced Targeting Systems
2. GIBCO Advanced D-MEM (Dulbeccos Modified Eagle Medium) (1X) liquid from Invitrogen
3. Electroporation Cuvettes, 4 mm gap. 50 from Thermo Scientific
4. ECM 630 Electroporation System from BTX
5. siPORTer™-96 Electroporation Chamber from Ambion
6. R.A.P.I.D. System from Idaho Technology Inc.
7. CEQ 8800 Genetic Analysis System from Beckman Coulter
8. ProteomeLab PA 800 Protein Characterization System from Beckman Coulter
9. ProteomeLab PF 2D Protein Fractionation System from Beckman Coulter
10. pET GST Fusion System 42 plus Competent Cells from Novagen
11. pET GST Fusion System 42 from Novagen
Anti-Indolamine (Indoleamine) 2,3-dioxygenase Immunogen: Recombinant human IDO. Available Date: 38454...
...
Rabbit monoclonal [EP881Y] to EEF2K ( Abpromise for all tested applications). Antigen: Synthetic peptide corresponding to residues in the C-terminal of human EEF2K. Entrez GeneID: 29904 S...
Weinreb Linker...
Biology Products:
(Date:7/9/2015)... SAN JOSE, Calif. , July 9, ... ), the leading developer of human interface ... authentication technology, the industry,s first fully hardware ... innovative Match-in-Sensor secure authentication technology is literally ... pattern storage and biometric matching within the ...
(Date:7/7/2015)... , June 30, 2015 ... announced the addition of the "Capacitive Fingerprint ... To this date, fingerprint sensing technology ... and fingerprint sensors are well developed. This patent ... technology. The domain of capacitive fingerprint ...
(Date:7/2/2015)... Fingerprint Cards has received an order for its ... distributor World Peace Industrial Group (WPI), part of WPG Holdings. ... . Deliveries are planned to take place during Q3 ... manufacturers in Asia . The order value ... of approximately 2,200 MSEK for 2015. Jörgen Lantto, ...
Breaking Biology News(10 mins):Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2
... cells) are involved in activating and directing other immune ... the over-aggressive responses of the T cell population. , ... anti-tumor Teff cells in order to better shape the ... from Memorial Sloan-Kettering Cancer Center, New York, demonstrated that ...
... function test scores by more than 15 percent in less ... second issue for July 2006 of the American Journal of ... Society. , Neil C. Thomson, M.D., of the Departments of ... seven associates studied 11 asthmatics who continued to smoke and ...
... only serves as a physical barrier against infection but skin ... microbes by producing antimicrobial polypeptides (AMPs). , As overt infection ... that AMPs must not only help fight infection, but play ... place. In a study appearing online on June 15 in ...
Cached Biology News:Quitting smoking improves lung function considerably 2
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... solutions, today announced its GHS Label Guide . To align chemical container ... (GHS), this guide includes explanations of label components, an example of an accurate ...
(Date:7/29/2015)... Madison, NJ (PRWEB) , ... July 29, 2015 , ... ... and approval of combination products , in particular, drug/device combinations. The current system ... innovation by the Initiative for Patient Centered Innovation (iPCI) of Fairleigh Dickinson ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... CHRONO NIGHT Express Contouring Bi-Gel, a nighttime-specific product that targets fat cells for ... that are able to enter fat cells, inhibiting the formation of new fat. ...
(Date:7/28/2015)... , July 29, 2015 ... acquiring, rapidly developing and commercialising innovative ... health   Highly experienced management team; blue ...   Mereo BioPharma Group Ltd ("Mereo"), ... raised $119m ( c. £76.5m), gross, from blue chip ...
Breaking Biology Technology:Brady Announces a New GHS Label Guide 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 3Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel 2Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 2Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 4Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 5Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 6Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 7Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 8Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 9Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 10Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 11